Clinical Trial

Prognostic Value of Isolated and Combined Score Aspects in Acute Ischemic Stroke

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 16, 2025 (before its estimated January 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study, called TARGET-ASPECT, looks at patients who had a type of stroke called acute ischemic stroke and were treated with clot-busting medicine and a procedure to remove the clot. Even with these treatments, about half of patients don't fully recover. The study aims to see if certain brain imaging scores, especially when combined, can better predict how well patients will recover 90 days after their stroke and if their blood vessels reopen successfully. The study will include 152 patients and last about 9 months. The goal is to find easy and reliable tools that doctors can use to make better treatment decisions.
Trial Details
NCT Number NCT07069452
Lead Sponsor Centre Hospitalier de Gonesse
Conditions Stroke, Ischemic, Thrombectomy, Thrombolytic Therapy, Brain Ischemia, Prognosis, Magnetic Resonance Imaging, Outcome Assessment (Health Care)
Enrollment 152 participants
Start Date 2025-04-15
Primary Completion 2026-01-15 (estimated)
Study Completion 2026-01-15 (estimated)
Updated on ClinicalTrials.gov 2025-07-16